Stimulation Tests

Stimulation tests are dynamic endocrine tests used to determine whether an endocrine gland or hormonal axis can respond appropriately to a controlled physiological or pharmacological stimulus. Instead of measuring a hormone only at baseline, a stimulation test evaluates how hormone concentrations change after the endocrine system is deliberately challenged.

These tests are particularly valuable when basal hormone concentrations cannot reliably demonstrate endocrine reserve. Many hormones are secreted in pulses, vary according to circadian rhythms, or fluctuate in response to stress, sleep, meals, and other physiological factors. A single measurement may therefore provide an incomplete picture of endocrine function.

Stimulation testing is commonly used in evaluation of the hypothalamic-pituitary-adrenal axis, growth hormone axis, and selected hypothalamic-pituitary-gonadal disorders. The test chosen depends on which level of the endocrine pathway is being investigated.

Principle of Stimulation Testing

An endocrine stimulation test introduces a stimulus that normally causes release of a particular hormone or activates a target endocrine gland.

Hormone concentrations are measured before and after the stimulus. The magnitude and timing of the response are then compared with expected physiological responses.

Basic Testing Sequence

A typical stimulation test follows several steps:

1. Obtain a baseline hormone measurement.
2. Administer a defined physiological or pharmacological stimulus.
3. Collect additional samples at predetermined intervals.
4. Measure the hormonal response.
5. Compare the response with validated assay-specific diagnostic criteria.

Basal Versus Dynamic Testing

Feature	Basal Testing	Stimulation Testing
Measurement	Hormone concentration at a particular time	Hormone response after a controlled stimulus
Main purpose	Assess current circulating concentration	Assess endocrine reserve or responsiveness
Sampling	Often one sample	Baseline plus one or more post-stimulation samples
Useful for pulsatile hormones	Sometimes limited	Often more informative

Endocrine Reserve

Endocrine reserve refers to the ability of an endocrine gland or hormonal pathway to increase hormone production when stimulated.

A gland may maintain a borderline basal hormone concentration yet fail to produce an adequate response when challenged. Dynamic testing can reveal this impaired reserve.

Endocrine Axes

Stimulation tests are best understood through the hierarchical organization of endocrine axes.

A typical hypothalamic-pituitary-target gland pathway can be represented as:

Hypothalamus → Pituitary gland → Peripheral endocrine gland → Target hormone

Stimulating different levels of this pathway can provide information about the functional capacity of downstream structures.

Major Stimulation Tests

Test	Primary Axis	Hormonal Response Assessed
ACTH stimulation test	Adrenal	Cortisol
Insulin tolerance test	HPA and growth hormone axes	Cortisol and growth hormone
Glucagon stimulation test	Growth hormone and adrenal axes	Growth hormone and sometimes cortisol
Growth hormone secretagogue testing	Growth hormone axis	Growth hormone
GnRH stimulation test	Gonadal axis	LH and FSH

ACTH Stimulation Test

The ACTH stimulation test, also called the cosyntropin stimulation test, evaluates the ability of the adrenal cortex to produce cortisol in response to ACTH stimulation.

It is one of the most commonly used dynamic tests in endocrinology and is primarily used when adrenal insufficiency is suspected.

Physiological Basis of the ACTH Test

Under normal conditions, ACTH is secreted by corticotroph cells of the anterior pituitary.

ACTH travels through the systemic circulation to the adrenal cortex, where it stimulates steroidogenesis, particularly cortisol production by the zona fasciculata.

Hypothalamic-Pituitary-Adrenal Axis

The normal pathway is:

Hypothalamus → CRH → Anterior pituitary → ACTH → Adrenal cortex → Cortisol

Cortisol then provides negative feedback to both the hypothalamus and anterior pituitary.

Cosyntropin

Cosyntropin is a synthetic analogue containing the biologically active portion of ACTH.

When administered, it directly stimulates ACTH receptors within the adrenal cortex, allowing adrenal cortisol-producing capacity to be assessed.

ACTH Test Procedure

A typical ACTH stimulation test involves:

1. Obtaining a baseline cortisol sample.
2. Administering cosyntropin.
3. Measuring cortisol at specified intervals after administration.
4. Assessing whether cortisol rises appropriately.

Exact protocols and diagnostic thresholds vary according to the cosyntropin dose, laboratory assay, and clinical setting.

Normal ACTH Response

In a person with adequate adrenal cortical reserve, cosyntropin stimulates a substantial increase in cortisol production.

The result is interpreted using the peak cortisol concentration and appropriate assay-specific criteria rather than a universal cutoff applicable to every laboratory.

Abnormal ACTH Response

An inadequate cortisol response indicates impaired adrenal cortisol-producing capacity.

The stimulation test alone does not always establish the anatomical level responsible for the abnormality. Baseline ACTH and other clinical information can help distinguish primary adrenal disease from central causes.

Primary Adrenal Insufficiency

In primary adrenal insufficiency, the adrenal cortex itself is damaged or dysfunctional.

Because the adrenal gland cannot respond normally to ACTH, cortisol demonstrates an inadequate rise after cosyntropin stimulation.

Loss of cortisol-mediated negative feedback also commonly produces elevated endogenous ACTH.

Secondary Adrenal Insufficiency

Secondary adrenal insufficiency results from inadequate ACTH secretion by the pituitary gland.

Prolonged ACTH deficiency can cause atrophy of ACTH-dependent regions of the adrenal cortex. As a result, the cortisol response to cosyntropin can become impaired.

Recent Central Adrenal Insufficiency

In relatively recent pituitary or hypothalamic ACTH deficiency, the adrenal cortex may retain sufficient functional capacity to respond to exogenous ACTH.

This means that a standard ACTH stimulation test can occasionally appear adequate despite clinically important recent central adrenal insufficiency.

Standard-Dose ACTH Test

The conventional ACTH stimulation test uses a pharmacological dose of cosyntropin to stimulate the adrenal cortex.

It is widely used because of its practical administration and established clinical experience.

Low-Dose ACTH Test

A low-dose ACTH stimulation test uses a smaller amount of cosyntropin intended to provide a more physiological stimulus.

It has been studied particularly for central adrenal insufficiency, although test preparation, dilution accuracy, protocols, and interpretation require careful standardization.

ACTH Test Interpretation

Finding	General Interpretation
Adequate cortisol rise	Suggests preserved adrenal cortisol-producing capacity
Inadequate cortisol rise	Suggests impaired adrenal reserve
Low cortisol + high baseline ACTH	Supports primary adrenal insufficiency
Low cortisol + low or inappropriately normal ACTH	Supports central adrenal insufficiency

Insulin Tolerance Test

The insulin tolerance test (ITT) evaluates endocrine responses to controlled hypoglycemia induced by insulin administration.

Hypoglycemia is a potent physiological stress that normally activates both the hypothalamic-pituitary-adrenal axis and growth hormone secretion.

Physiological Basis of the ITT

Falling blood glucose is detected as a significant metabolic stress.

Counter-regulatory responses include increased secretion of ACTH, cortisol, growth hormone, glucagon, and catecholamines.

Measuring cortisol and growth hormone responses can therefore provide information about the integrity of central endocrine pathways.

ITT and the HPA Axis

Hypoglycemic stress activates hypothalamic corticotropin-releasing hormone pathways, increasing pituitary ACTH secretion and subsequently adrenal cortisol production.

The test therefore assesses the integrated function of the hypothalamus, pituitary gland, and adrenal cortex rather than stimulating the adrenal gland directly.

ITT and Growth Hormone

Hypoglycemia also stimulates growth hormone release from pituitary somatotrophs.

The ITT can therefore be used to evaluate suspected growth hormone deficiency in selected patients.

Limitations of the Insulin Tolerance Test

The ITT intentionally produces hypoglycemia and requires close clinical monitoring.

It is unsuitable for some patients, particularly when induced hypoglycemia could create substantial risk. Patient selection, supervision, and appropriate protocols are therefore essential.

Growth Hormone Stimulation Testing

Growth hormone is secreted in pulses, with substantial variation over the course of the day.

Because concentrations between secretory pulses can be very low even in healthy individuals, a random growth hormone measurement cannot reliably diagnose growth hormone deficiency.

Growth Hormone Axis

The growth hormone axis involves several levels of regulation:

Hypothalamus → GHRH and somatostatin → Anterior pituitary → Growth hormone → Liver and other tissues → IGF-1

Growth hormone-releasing hormone promotes GH secretion, while somatostatin inhibits it.

IGF-1

Insulin-like growth factor 1 (IGF-1) is produced largely by the liver in response to growth hormone.

IGF-1 concentrations are more stable than GH concentrations and provide useful information about the growth hormone axis, but dynamic testing may still be necessary when growth hormone deficiency is suspected.

Principle of GH Stimulation

Growth hormone stimulation tests use physiological or pharmacological stimuli capable of provoking GH release.

Serial blood samples are then collected to determine the peak GH response.

Growth Hormone Secretagogues

Pharmacological agents that stimulate growth hormone secretion can be used for dynamic assessment of the GH axis.

The appropriate agent and interpretation depend on patient characteristics, local protocols, and validated diagnostic thresholds.

Glucagon Stimulation Test

The glucagon stimulation test can be used as an alternative dynamic test for growth hormone reserve in selected patients.

After glucagon administration, serial measurements of growth hormone are obtained over a defined period.

Glucagon and Cortisol

Glucagon stimulation has also been used to assess the hypothalamic-pituitary-adrenal axis in selected circumstances.

The physiological mechanism by which glucagon stimulates these hormonal responses is indirect and more complex than direct ACTH stimulation of the adrenal cortex.

Arginine Stimulation

Arginine can stimulate growth hormone secretion partly by reducing somatostatin-mediated inhibition of GH release.

It has historically been used alone or in combination with other stimuli for evaluation of growth hormone reserve.

Macimorelin Stimulation

Macimorelin is an orally active growth hormone secretagogue that stimulates GH release through the ghrelin receptor pathway.

Serial GH measurements after administration can be used for diagnosis of adult growth hormone deficiency in appropriate settings.

Interpreting GH Stimulation Tests

The peak growth hormone response is compared with thresholds validated for the particular stimulation test and assay.

Interpretation can be influenced by age, body composition, sex hormones, nutritional status, and the analytical method used to measure GH.

Body Mass and GH Response

Growth hormone responses to stimulation can be lower in individuals with greater adiposity.

Body mass index and other patient characteristics may therefore need to be considered when interpreting selected GH stimulation tests.

GnRH Stimulation Test

The gonadotropin-releasing hormone (GnRH) stimulation test evaluates pituitary secretion of luteinizing hormone and follicle-stimulating hormone after stimulation with GnRH or an appropriate analogue.

Hypothalamic-Pituitary-Gonadal Axis

The reproductive endocrine pathway is:

Hypothalamus → GnRH → Anterior pituitary → LH and FSH → Gonads → Sex steroids and inhibins

GnRH is normally secreted in pulses and acts on gonadotroph cells within the anterior pituitary.

LH Response

After GnRH stimulation, pituitary gonadotrophs release luteinizing hormone (LH).

The magnitude and pattern of the response depend on developmental stage, gonadal feedback, and the functional state of the hypothalamic-pituitary-gonadal axis.

FSH Response

Follicle-stimulating hormone (FSH) can also increase following GnRH stimulation.

LH and FSH responses are interpreted together with age, sex, pubertal development, and baseline hormone concentrations.

GnRH Testing in Pubertal Disorders

GnRH-based stimulation testing can be used in selected evaluations of disorders involving pubertal development.

The response of pituitary gonadotropins can provide information about activation of the hypothalamic-pituitary-gonadal axis.

Central Precocious Puberty

In central precocious puberty, the hypothalamic-pituitary-gonadal axis becomes activated earlier than expected.

A pubertal pattern of stimulated gonadotropin secretion can support evidence of central activation when interpreted together with clinical findings and other investigations.

Delayed Puberty

Dynamic assessment of gonadotropin secretion has also been used in selected cases of delayed puberty.

Interpretation can be complex because normal developmental variation and constitutional delay can overlap with pathological endocrine conditions.

TRH Stimulation Test

The thyrotropin-releasing hormone (TRH) stimulation test evaluates pituitary TSH secretion following administration of TRH.

It illustrates the physiological relationship between the hypothalamus and pituitary within the thyroid axis, although modern sensitive TSH assays have greatly reduced its routine clinical use.

Hypothalamic-Pituitary-Thyroid Axis

The thyroid regulatory pathway is:

Hypothalamus → TRH → Anterior pituitary → TSH → Thyroid gland → T4 and T3

Circulating thyroid hormones provide negative feedback to the pituitary and hypothalamus.

TSH Response to TRH

TRH normally stimulates pituitary thyrotrophs to release TSH.

Historically, the timing and magnitude of the TSH response were used to investigate abnormalities within the hypothalamic-pituitary-thyroid axis.

Reduced Role of TRH Testing

Modern highly sensitive TSH assays and direct measurement of free thyroid hormones allow most thyroid disorders to be evaluated without TRH stimulation testing.

The test is therefore mainly important for understanding endocrine physiology and has limited routine use compared with contemporary thyroid laboratory testing.

CRH Stimulation Test

Corticotropin-releasing hormone (CRH) stimulates pituitary corticotrophs to release ACTH.

Administration of CRH followed by measurement of ACTH and cortisol responses can provide information about the hypothalamic-pituitary-adrenal axis in selected specialized evaluations.

CRH Physiology

CRH is produced by neurons within the hypothalamus and released into the hypothalamic-hypophyseal portal circulation.

It reaches the anterior pituitary, where it stimulates ACTH secretion from corticotroph cells.

ACTH and Cortisol Responses to CRH

Following CRH stimulation, ACTH can increase, followed by an increase in adrenal cortisol production.

The pattern of these responses can provide information about different levels of the HPA axis in specialized clinical settings.

Stimulation Versus Suppression Tests

Dynamic endocrine testing includes both stimulation and suppression approaches.

Stimulation tests are generally used when inadequate hormone production is suspected, while suppression tests are commonly useful when inappropriate hormone excess is suspected.

Test Type	General Question	Example
Stimulation test	Can the endocrine system increase hormone output appropriately?	ACTH stimulation test
Suppression test	Can excessive hormone secretion be appropriately suppressed?	Dexamethasone suppression test

Timing of Samples

Timing is critical during stimulation testing because different hormones respond at different rates after a stimulus.

Samples are collected according to standardized protocols designed around the expected physiological response of the hormone being tested.

Peak Hormone Response

Some stimulation tests are interpreted primarily according to the highest hormone concentration reached after stimulation.

The timing of the peak can vary between individuals, which is one reason multiple post-stimulation samples may be obtained.

Incremental Response

In some circumstances, both the absolute stimulated concentration and the increase from baseline can provide useful information.

Modern interpretation generally relies on validated criteria specific to the test, hormone assay, and clinical setting.

Assay-Specific Thresholds

Diagnostic thresholds for endocrine stimulation tests are not necessarily interchangeable between laboratories.

Modern hormone assays can differ in calibration, analytical specificity, and measured concentrations. Interpretation should therefore use criteria appropriate for the assay being used.

Factors Affecting Test Results

Several factors can influence dynamic endocrine testing:

• Age
• Body composition
• Time of day
• Acute illness
• Stress
• Sleep
• Nutritional status
• Pregnancy
• Sex hormone status
• Medications
• Recent glucocorticoid exposure
• Laboratory assay methodology

Medication Effects

Medications can alter hormone production, receptor responses, metabolism, or laboratory measurements.

Medication history must therefore be considered before performing and interpreting a stimulation test.

Glucocorticoid Therapy

Prolonged exposure to exogenous glucocorticoids can suppress hypothalamic CRH and pituitary ACTH secretion.

After glucocorticoid withdrawal, recovery of the hypothalamic-pituitary-adrenal axis can take time, and dynamic testing may be used in selected situations to assess adrenal recovery.

Acute Illness and Stress

Acute illness and physiological stress can substantially alter cortisol, growth hormone, glucose, and other endocrine pathways.

Testing performed during major illness may therefore require different interpretation from testing performed under stable outpatient conditions.

Safety Considerations

Dynamic endocrine tests vary substantially in physiological effect and risk.

Tests that intentionally induce hypoglycemia or other major physiological changes require appropriate patient selection, monitoring, trained personnel, and access to treatment if adverse effects occur.

Stimulation Testing and Imaging

Stimulation testing evaluates function, while endocrine imaging evaluates structure.

A functional abnormality identified through laboratory testing can guide subsequent imaging when anatomical localization is necessary.

Functional Diagnosis Before Localization

In many endocrine disorders, biochemical confirmation is obtained before imaging is used to search for a responsible lesion.

This reduces the risk of incorrectly attributing a hormonal abnormality to an incidental structural lesion.

Examples of Functional and Structural Assessment

Clinical Question	Functional Assessment	Potential Structural Assessment
Adrenal insufficiency	Cortisol, ACTH and ACTH stimulation testing	Adrenal or pituitary imaging when indicated
Growth hormone deficiency	IGF-1 and GH stimulation testing	Pituitary MRI when indicated
Central pubertal disorder	Gonadotropins with selected stimulation testing	Hypothalamic-pituitary imaging when indicated

Advantages of Stimulation Tests

• Assess functional endocrine reserve
• Can reveal abnormalities not evident from basal hormone concentrations
• Evaluate integrated endocrine pathways
• Can help distinguish normal physiological variation from impaired hormonal responsiveness
• Provide standardized challenges for assessing endocrine function

Limitations of Stimulation Tests

• Some tests require prolonged serial sampling
• Protocols differ between tests and institutions
• Results can depend on assay methodology
• Physiological factors can alter responses
• Some tests require close medical supervision
• Not every test reliably distinguishes the anatomical level of dysfunction by itself

Common Stimulation Tests Summary

Test	Stimulus	Measured Response	Major Application
ACTH stimulation	Cosyntropin	Cortisol	Adrenal insufficiency
Insulin tolerance	Insulin-induced hypoglycemia	GH and cortisol	Selected GH and HPA-axis evaluation
Glucagon stimulation	Glucagon	GH, sometimes cortisol	Selected assessment of GH or adrenal reserve
Macimorelin	GH secretagogue	Growth hormone	Adult GH deficiency
GnRH stimulation	GnRH or analogue	LH and FSH	Selected pubertal disorders
TRH stimulation	TRH	TSH	Historical or specialized thyroid-axis assessment
CRH stimulation	CRH	ACTH and cortisol	Specialized HPA-axis evaluation

Key Features of Stimulation Tests

Feature	Key Point
Primary purpose	Assess endocrine functional reserve
Basic method	Measure hormone concentrations before and after a controlled stimulus
ACTH stimulation	Tests adrenal cortisol-producing capacity
GH stimulation	Evaluates pituitary growth hormone reserve
Insulin tolerance test	Uses hypoglycemic stress to activate GH and HPA responses
GnRH stimulation	Assesses pituitary gonadotropin response
Dynamic sampling	Requires appropriately timed post-stimulation measurements
Interpretation	Depends on the test, assay, patient characteristics, and clinical context
Relationship to imaging	Functional testing can identify abnormalities before structural localization

Anatomical and Physiological Importance

Stimulation tests demonstrate how endocrine anatomy can be investigated through physiology. The endocrine system is organized into interconnected levels, including the hypothalamus, anterior pituitary, peripheral endocrine glands, and target tissues. By stimulating a specific point in this pathway and measuring downstream hormone production, clinicians can assess whether the relevant tissues retain functional capacity.

The ACTH stimulation test provides a clear example. Administration of synthetic ACTH bypasses the hypothalamus and pituitary and directly challenges the adrenal cortex. The subsequent cortisol response therefore provides information about adrenal cortical reserve. Baseline ACTH concentrations and other findings can then help determine whether impaired function originates primarily within the adrenal gland or from central regulatory dysfunction.

Growth hormone testing illustrates a different problem. Because GH is naturally secreted in pulses, a random low concentration does not necessarily indicate deficiency. A controlled stimulus is therefore used to provoke GH secretion, allowing pituitary reserve to be assessed more meaningfully.

Dynamic endocrine testing consequently provides information that static anatomical imaging and isolated hormone measurements cannot always provide. When combined with basal hormone measurements, feedback relationships, clinical findings, and appropriate imaging, stimulation tests can help identify both the presence and physiological level of endocrine dysfunction.